Product Program year 2025 Source: CMS Open Payments

Yeztugo

Drug Hiv

NDC 61958-3401-1

Open in the dashboard

General payments

$2,392,876

5,589 payments

Research payments

$5,411,514

783 payments

Through program year 2025, $2,392,876 in general payments and $5,411,514 in research payments were reported against Yeztugo (Hiv).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $2,392,876 5,589
2025 Research $5,411,514 783

Breakdown

Who paid General payments · program year 2025
  1. Gilead Sciences, Inc. $2,392,876 5,589 payments
Top recipients General payments · program year 2025
  1. Wilfredo Giordano-Perez Family Medicine · Johnston, RI $68,520 3% · 67 payments
  2. Noah Lee Family Medicine · Oakland Park, FL $39,736 2% · 34 payments
  3. Nasser Mohamed Family Medicine · San Francisco, CA $38,698 2% · 42 payments
  4. Nicholaos Bellos Internal Medicine · Dallas, TX $37,146 2% · 25 payments
  5. Theo Hodge Infectious Disease · Washington, DC $36,293 2% · 26 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $503,327 21% · 188 practitioners
  2. Internal Medicine $471,594 20% · 270 practitioners
  3. Family Medicine $457,983 19% · 394 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $277,643 12% · 746 practitioners
  5. Physician Assistant $147,202 6% · 257 practitioners

The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $402,898 17% · 547 recipients
  2. New York $305,840 13% · 339 recipients
  3. Florida $232,500 10% · 213 recipients
  4. Texas $163,132 7% · 180 recipients
  5. Massachusetts $137,123 6% · 95 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,589 general · 783 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record